David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$9.63B |
| 2 |
Amazon
AMZN
|
+$1.56B |
| 3 |
NVIDIA
NVDA
|
+$1.1B |
| 4 |
Meta Platforms (Facebook)
META
|
+$924M |
| 5 |
SPCX
SpaceX
SPCX
|
+$907M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$2.17B |
| 2 |
Broadcom
AVGO
|
+$1.53B |
| 3 |
Microsoft
MSFT
|
+$1.05B |
| 4 |
TSMC
TSM
|
+$928M |
| 5 |
Texas Instruments
TXN
|
+$904M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.78% |
| 2 | Financials | 8.35% |
| 3 | Healthcare | 7.91% |
| 4 | Consumer Discretionary | 7.83% |
| 5 | Industrials | 7.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4451
Braskem
BAK
$793M
| $192K | ﹤0.01% |
+78,880
| New | +$298K |
|
|
CCRN
4452
DELISTED
Cross Country Healthcare
CCRN
| $190K | ﹤0.01% |
14,397
-57,583
| -80% | -$682K |
|
|
RUMBW
4453
RUM Group Inc Warrant
RUMBW
$16.1M
| $189K | ﹤0.01% |
106,572
| – | – |
|
|
RAAQW
4454
DELISTED
Real Asset Acquisition Corp Warrants
RAAQW
| $181K | ﹤0.01% |
50,000
| – | – |
|
4455
Archer Aviation Redeemable Warrants
ACHR.WS
$9.61M
| $181K | ﹤0.01% |
1,507,382
| – | – |
|
4456
Forrester Research
FORR
$224M
| $180K | ﹤0.01% |
21,389
-4,422
| -17% | -$28.9K |
|
4457
CALL
Sarepta Therapeutics
SRPT
$1.98B
| $180K | ﹤0.01% |
+10,000
| New | +$189K |
|
|
OCSAW
4458
Oculis Holding AG Warrants
OCSAW
$264M
| $174K | ﹤0.01% |
34,716
| – | – |
|
|
XZO
4459
Exzeo Group
XZO
$1.52B
| $172K | ﹤0.01% |
+10,170
| New | +$150K |
|
4460
Sagimet Biosciences
SGMT
$637M
| $171K | ﹤0.01% |
22,177
-389,393
| -95% | -$2.65M |
|
|
TRAD
4461
APEX Tech Acquisition Inc
TRAD
$147M
| $171K | ﹤0.01% |
+17,221
| New | +$171K |
|
4462
Evolution Petroleum
EPM
$127M
| $171K | ﹤0.01% |
46,464
+18,776
| +68% | +$82.1K |
|
|
CXIIW
4463
Churchill Capital Corp XII Warrants
CXIIW
$7.12M
| $170K | ﹤0.01% |
+100,000
| New | +$134K |
|
4464
Accuray
ARAY
$33.6M
| $167K | ﹤0.01% |
649,353
-194,293
| -23% | -$72.3K |
|
4465
Crescent Capital BDC
CCAP
$395M
| $164K | ﹤0.01% |
14,973
-13,061
| -47% | -$159K |
|
4466
Infosys
INFY
$48.4B
| $162K | ﹤0.01% |
15,429
-512,896
| -97% | -$6.42M |
|
4467
Geron
GERN
$977M
| $159K | ﹤0.01% |
+123,931
| New | +$175K |
|
4468
Montauk Renewables
MNTK
$268M
| $158K | ﹤0.01% |
101,497
-16,759
| -14% | -$24.8K |
|
4469
Aquestive Therapeutics
AQST
$585M
| $157K | ﹤0.01% |
37,640
+19,491
| +107% | +$82K |
|
4470
Heartland Express
HTLD
$993M
| $156K | ﹤0.01% |
10,225
-28,884
| -74% | -$391K |
|
4471
LegalZoom.com
LZ
$998M
| $152K | ﹤0.01% |
24,812
-169,308
| -87% | -$1.04M |
|
|
OGG
4472
Osisko Gold Group
OGG
$939M
| $148K | ﹤0.01% |
60,345
-373,031
| -86% | -$1.11M |
|
|
VZLA
4473
Vizsla Silver
VZLA
$1.39B
| $147K | ﹤0.01% |
44,449
-67,691
| -60% | -$235K |
|
4474
PUT
Joby Aviation
JOBY
$7.45B
| $144K | ﹤0.01% |
+16,100
| New | +$156K |
|
|
NUAIW
4475
New Era Energy & Digital Inc Warrants
NUAIW
$15.2M
| $143K | ﹤0.01% |
49,999
| – | – |
|
Similar funds
David Shaw's Q2 2026 Portfolio in Review
As of Q2 2026, David Shaw held 5,360 positions worth $210B, up 26% from $166B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
David Shaw deployed $7.01B of net new capital in Q2 2026, opening 872 new positions and adding to 1,718 existing holdings. Its largest new stake was SpaceX: 5,340,000 shares worth $912M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 19% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Micron Technology, an estimated $2.17B trimmed.
- David Shaw's largest Q2 2026 buy was SpaceX: 5,340,000 shares worth $912M.
- David Shaw added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $9.63B increase.
- David Shaw's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $2.17B.
- David Shaw fully exited Automatic Data Processing in Q2 2026, selling an estimated $241M.
- David Shaw's ten largest holdings make up 15% of its $210B portfolio in Q2 2026.
- David Shaw opened 872 new positions and closed 527 in Q2 2026.
- David Shaw's portfolio value rose 26% quarter-over-quarter to $210B.
Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.